Merck & Company (MRK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2000 | 12-1999 | 12-1998 | 12-1997 | 12-1996 | |
| Sales | 40,363,200 | 32,714,000 | 26,898,200 | 23,636,900 | 19,828,700 |
| Cost of Goods | 22,443,500 | 17,534,200 | 13,925,400 | 11,790,300 | 9,319,200 |
| Gross Profit | 17,919,700 | 15,179,800 | 12,972,800 | 11,846,600 | 10,509,500 |
| Operating Expenses | 8,512,000 | 7,268,400 | 6,332,900 | 6,325,900 | 5,569,600 |
| Operating Income | 9,408,199 | 7,911,600 | 6,640,299 | 5,521,000 | 4,940,100 |
| Other Income | 415,901 | 707,900 | 1,492,801 | 941,300 | 600,700 |
| Pre-tax Income | 9,824,100 | 8,619,500 | 8,133,100 | 6,462,300 | 5,540,800 |
| Income Tax | 3,002,400 | 2,729,000 | 2,884,900 | 1,848,200 | 1,659,500 |
| Net Income Continuous | 6,821,700 | 5,890,500 | 5,248,200 | 4,614,100 | 3,881,300 |
| Net Income | $6,821,700 | $5,890,500 | $5,248,200 | $4,614,100 | $3,881,300 |
| EPS Basic Total Ops | 2.96 | 2.51 | 2.21 | 1.92 | 1.60 |
| EPS Basic Continuous Ops | 2.96 | 2.51 | 2.21 | 1.92 | 1.60 |
| EPS Diluted Total Ops | 2.90 | 2.45 | 2.15 | 1.87 | 1.60 |
| EPS Diluted Continuous Ops | 2.90 | 2.51 | 2.21 | 1.87 | 1.60 |
| EBITDA(a) | $10,676,600 | $9,056,399 | $7,655,399 | $6,358,100 | $5,671,000 |